Somite.ai

A TechBio company leveraging foundation models and proprietary AI to accelerate human cell therapy development.

Health Tech & Life Sciences
Active
Series A Tel Aviv, Israel Founded 2023
Last updated 2026-07-26
Total raised
$57.5M
Last: Undisclosed Round 2025-05
Stage
Series A
Founded
2023
Headcount
30
HQ
Tel Aviv, Israel
Sector
Health Tech & Life Sciences

About

Somite.ai is a TechBio company that develops AI foundation models for human stem cells to drive novel cell therapies at scale. The company's DeltaStem platform aims to revolutionize the production of any human cell type to address a broad spectrum of diseases, including metabolic disorders, orthopedic conditions, muscular diseases, and blood disorders. Somite.ai takes a full-stack approach, generating data at significantly lower costs, training large-scale AI models, and leveraging these models to discover, refine, and optimize cell therapy applications. The company is developing a computational model, a digital twin of the embryo, to simulate its development and behavior. This AI-powered approach aims to guide decision-making in the creation of human tissue for cell-based therapies, with the mission to transform the lives of millions.

Funding history · 3 rounds · $57.5M total

2025-04
A Round $47.5M
★ Khosla VenturesTechAvivScifi VCAjinomotoFusion FundMartin ChavezHarpoon VenturesPitango HealthTechChan Zuckerberg Initiative
2024-08
Seed $4.7M
★ Montage Ventures★ Astellas Venture Management
2024-03
Pre-Seed $5.3M
★ TechAviv Founder PartnersTrust VenturesNext Coast VenturesTexas Venture PartnersLerer Hippeau Ventures

Headcount over time

From 30 (2024-03) to 57 (2026-03) · +27 (+90%) · 7 points · source: Finder history + radar grounding
570 2024-03 2026-03

Q&A

What is Somite.ai's primary focus?
Somite.ai is a TechBio company that leverages foundation models and proprietary AI to accelerate human cell therapy development, aiming to revolutionize the production of human cell types for various diseases.
When was Somite.ai founded?
Somite.ai was founded in October 2023.
How much funding has Somite.ai raised to date?
Somite.ai has raised a total of $60,000,000 USD.
Which investors participated in Somite.ai's Series A funding round?
In May 2025, Somite.ai secured a Series A round of $47,000,000, led by Khosla Ventures.
What was the amount of Somite.ai's initial Pre-Seed funding round?
In April 2024, Somite.ai raised $5,300,000 in a Pre-Seed round, with TechAviv as a lead investor.
What is the employee count for Somite.ai?
Somite.ai has an employee count in the 11-50 range.
Where is Somite.ai headquartered?
Somite.ai is headquartered in Tel Aviv, Israel, with an additional office in Boston, United States.
What is the name of Somite.ai's platform?
Somite.ai's platform is called DeltaStem, which is designed to revolutionize the production of human cells.

Team · 6

Dr. Micha Breakstone
Founder · Co-founder & CEO
Dr. Jonathan Rosenfeld
Founder · Co-founder & Head of Fundamental AI Group at MIT
Prof. Olivier Pourquié
Founder · Scientific Co-founder
Prof. Allon Klein
Founder · Scientific Co-founder
Prof. Jay Shendure
Founder · Scientific Co-founder
Prof. Cliff Tabin
Founder · Scientific Co-founder

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue Engineering
Technologies
Artificial Intelligence
Target customers
Healthcare & Life SciencesLife SciencesBiotechnology
Business model
B2C

Highlights

Verified

Tags

artificial-intelligencecell-therapystem-cells
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitecellularintelligence.com
LinkedInlinkedin.com/company/98835010

Identifiers & details

Legal nameSomite Therapeutics Inc.
Founded2023-10
Employees (exact)30
OfficesBoston

Radar intelligence

Web history (Wayback)

Domaincellularintelligence.com

Certificate / subdomain footprint

Subdomains3